Company intelligence / Profile preview

Yes Agency

Mississauga/Toronto, Ontario, Canadayes.agency ↗

Ownership: Private
Development stage: Other

Overview

Anogen has developed and commercialized over 300 monoclonal and polyclonal antibodies and more than 60 ELISA kits for research and diagnostics. Their anti-interleukin 8 monoclonal antibody topical treatment ("Abcream") received regulatory approval in China for psoriasis in 2001. They have also conducted preclinical work on Alzheimer’s disease using anti-Abeta42 and anti-Tau antibodies.

Therapeutic areas: OncologyDermatologyImmunologyNeurology
Modalities: Monoclonal antibodyPolyclonal antibodySmall molecule
Industry: Biotech

Partnerships

Huapont Pharma partnership on psoriasis product development

Beyond the preview

Go deeper on Yes Agency.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yes Agency.

Explore the full profile